[HTML][HTML] Treating bacterial infections with bacteriophage-based enzybiotics: in vitro, in vivo and clinical application
Over the past few decades, we have witnessed a surge around the world in the emergence
of antibiotic-resistant bacteria. This global health threat arose mainly due to the overuse and …
of antibiotic-resistant bacteria. This global health threat arose mainly due to the overuse and …
[HTML][HTML] Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
B Maciejewska, T Olszak, Z Drulis-Kawa - Applied microbiology and …, 2018 - Springer
Bacteriophages (phages) are viruses that infect bacteria. The “predator–prey” interactions
are recognized as a potentially effective way to treat infections. Phages, as well as phage …
are recognized as a potentially effective way to treat infections. Phages, as well as phage …
Antimicrobial bacteriophage-derived proteins and therapeutic applications
DR Roach, DM Donovan - Bacteriophage, 2015 - Taylor & Francis
Antibiotics have the remarkable power to control bacterial infections. Unfortunately,
widespread use, whether regarded as prudent or not, has favored the emergence and …
widespread use, whether regarded as prudent or not, has favored the emergence and …
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections
Endolysins are the lytic products of bacteriophages which play a specific role in the release
of phage progeny by degrading the peptidoglycan of the host bacterium. In the light of …
of phage progeny by degrading the peptidoglycan of the host bacterium. In the light of …
Synthetic biology of modular endolysins
H Gerstmans, B Criel, Y Briers - Biotechnology advances, 2018 - Elsevier
Endolysins and their derivatives have emerged in recent years as a novel class of
antibacterials, which have now entered the clinical phases. Their rapid mode-of-action and …
antibacterials, which have now entered the clinical phases. Their rapid mode-of-action and …
Bacteriophage endolysins: applications for food safety
M Schmelcher, MJ Loessner - Current opinion in biotechnology, 2016 - Elsevier
Highlights•Endolysins are promising agents for detection and control of foodborne
pathogens.•Cell wall binding domains can be used for specific detection of bacteria in …
pathogens.•Cell wall binding domains can be used for specific detection of bacteria in …
[HTML][HTML] A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
M Guo, C Feng, J Ren, X Zhuang, Y Zhang… - Frontiers in …, 2017 - frontiersin.org
The global increase in multidrug resistant (MDR) bacteria has led to phage therapy being
refocused upon. A novel endolysin, LysPA26, containing a lysozyme-like domain, was …
refocused upon. A novel endolysin, LysPA26, containing a lysozyme-like domain, was …
Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria
The emergence and spread of antibiotic-resistant bacteria drives the search for novel
classes of antibiotics to replenish our armamentarium against bacterial infections. This is …
classes of antibiotics to replenish our armamentarium against bacterial infections. This is …
Factors determining phage stability/activity: challenges in practical phage application
E Jończyk-Matysiak, N Łodej, D Kula… - Expert review of anti …, 2019 - Taylor & Francis
Introduction: Phages consist of nucleic acids and proteins that may lose their activity under
different physico-chemical conditions. The production process of phage formulations may …
different physico-chemical conditions. The production process of phage formulations may …
[HTML][HTML] Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
Objectives Multidrug-resistant (MDR) bacteria are a major public-health concern.
Bacteriophage endolysins (lysins) can be used as novel antimicrobial agents against …
Bacteriophage endolysins (lysins) can be used as novel antimicrobial agents against …